Impact on postpartum hemorrhage of prophylactic administration of oxytocin 10 IU via Uniject(TM) by peripheral health care providers at home births: design of a community-based cluster-randomized trial

BACKGROUND: Hemorrhage is the leading direct cause of maternal death globally. While oxytocin is the drug of choice for postpartum hemorrhage prevention, its use has generally been limited to health facilities. This trial assesses the effectiveness, safety, and feasibility of expanding the use of pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanton, Cynthia K, Newton, Samuel, Mullany, Luke C, Cofie, Patience, Agyemang, Charlotte Tawiah, Adiibokah, Edward, Darcy, Niamh, Khan, Sadaf, Levisay, Alice, Gyapong, John, Armbruster, Deborah, Owusu-Agyei, Seth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406972/
https://www.ncbi.nlm.nih.gov/pubmed/22676921
http://dx.doi.org/10.1186/1471-2393-12-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406972/
https://www.ncbi.nlm.nih.gov/pubmed/22676921
http://dx.doi.org/10.1186/1471-2393-12-42

Ejemplares similares